BIOLIFE SOLUTIONS INC (BLFS)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

16 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013201220112010
Revenue$96.2M$74.6M$68.0M$76.2M$119.2M$48.1M$27.4M$19.7M$11.0M$6.2M$8.9M$5.7M$2.8M$2.1M
Gross profit$62.1M$50.1M$41.3M$13.5M$6.7M$4.8M$3.8M$3.0M$3.8M$2.3M$1.4M$856,388
Research & development$7.6M$4.8M$5.5M$8.7M$11.8M$6.7M$3.2M$1.3M$1.2M$2.0M$1.4M$871,100$487,816$463,638$516,454$318,897
Operating expenses$9.9M$7.8M$9.6M$8.8M$6.2M$4.0M$3.2M$2.6M$2.3M
Operating income−$16.6M−$4.5M−$17.2M−$5.9M−$35.2M−$6.2M−$220,000$3.7M−$1.1M−$4.9M−$5.0M−$3.1M−$285,357−$942,238−$1.2M−$1.4M
EBITDAderived−$14.3M$683,000−$10.1M$852,000−$30.5M−$4.2M$498,000
Net income−$4.6M−$20.2M−$68.0M−$139.8M−$8.9M$2.0M−$1.7M−$25.0M−$2.5M−$6.9M−$4.2M−$3.2M−$1.1M−$1.7M−$2.0M−$2.0M
Basic EPSper diluted share-$0.09-$0.44-$1.55-$3.29-$0.23$0.07-$0.09-$1.56-$0.21-$0.54-$0.35-$0.31-$0.22-$0.33-$0.03-$0.03
Diluted EPSper diluted share-$0.10-$0.44-$1.55-$3.25-$0.23-$0.06-$0.09-$1.56-$0.21-$0.54-$0.35-$0.31-$0.22-$0.33-$0.03-$0.03

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)164$110.75M disclosed value
164 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
May 21, 2026Form 4Casdin Partners Master Fund, L.P. +3TenPercentOwnerSellCommon Stock, par value $0.001 per share · indirect650.0K$23.70$15.40M4.76M
May 20, 2026Form 4Casdin Partners Master Fund, L.P. +3TenPercentOwnerSellCommon Stock, par value $0.001 per share · indirect250.0K$23.70$5.92M5.41M
May 19, 2026Form 4Casdin Partners Master Fund, L.P. +3TenPercentOwnerSellCommon Stock, par value $0.001 per share · indirect300.0K$22.65$6.79M5.66M
Mar 23, 2026Form 4 · 10b5-1Foster Karen A.Chief Quality and OperationsSellCommon Stock2.6K$19.17$49.4K108.8K
Mar 9, 2026Form 4Foster Karen A.Chief Quality and OperationsSellCommon Stock500$20.00$10.0K113.2K